Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies.
Horizon Discovery Group is a company that supplies genetically defined cell lines, in vivo models, reference standards, and contract research services to academia and biopharma.
Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
Singular Genomics Systems is a life science technology company that develops next-generation sequencing (NGS) and multi-omics technologies to build products for researchers and clinicians.